Kinetics of histone H2AX phosphorylation and Chk2 activation in A549 cells treated with topotecan and mitoxantrone in relation to the cell cycle phase.
about
DNA damage signaling assessed in individual cells in relation to the cell cycle phase and induction of apoptosisDNA damage response induced by tobacco smoke in normal human bronchial epithelial and A549 pulmonary adenocarcinoma cells assessed by laser scanning cytometryVitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell linesOxidative stress induces cell cycle-dependent Mre11 recruitment, ATM and Chk2 activation and histone H2AX phosphorylation.Induction of DNA damage response by the supravital probes of nucleic acids.Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cellsOn the quantification of intracellular proteins in multifluorescence-labeled rat brain slices using slide-based cytometry.Analysis of individual molecular events of DNA damage response by flow- and image-assisted cytometryRelationship of DNA damage signaling to DNA replication following treatment with DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone, or etoposideDNA damage detected with gammaH2AX in endometrioid adenocarcinoma cell lines.A high-throughput, flow cytometry-based method to quantify DNA-end resection in mammalian cells.Laser scanning cytometry: principles and applications-an update.HPV16-E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma.Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.H2AX a promising biomarker for lung cancer: a review.Mitoxantrone, More than Just Another Topoisomerase II Poison.Comparison of methods to quantify histone H2AX phosphorylation and its usefulness for prediction of radiosensitivity.Quantitative measurement of alterations in DNA damage repair (DDR) pathways using single cell network profiling (SCNP)CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute.Helicobacter hepaticus cytolethal distending toxin causes cell death in intestinal epithelial cells via mitochondrial apoptotic pathway.Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide.Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.Cell synchronization by inhibitors of DNA replication induces replication stress and DNA damage response: analysis by flow cytometry.Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pumpMolecular basis for the DNA damage induction and anticancer activity of asymmetrically substituted anthrapyridazone PDZ-7.
P2860
Q26822413-20A8A752-C115-4D4E-9FCB-59F2CB8FA1EBQ28393323-87E97E44-BB34-41B6-A86F-6F5465E7DE02Q28542814-501C8ED2-A493-461E-B9E3-BCAF4E62839CQ33328797-CC2ADD63-E399-4B84-8893-3B6861D59410Q33431359-11BA47E2-F781-44E5-917F-BE2E4439502BQ33638864-5E536E1B-00CC-4D38-890F-555EDFF3273BQ33852155-D0EE1078-F427-4AC3-AD59-373B5B3267A4Q33948911-0C9E65CE-A461-4C96-83BB-25668C81C818Q34090630-D05E7ACD-B01C-4418-88F7-20CB1D5FC607Q34275075-70E8B73A-3F8D-47ED-B323-1F4A40BA8DE3Q34380080-16697846-58B0-4B75-B22D-7A5A05D956DFQ34425863-D041E071-8252-4E4E-8997-F120787E55E4Q36544275-6B13D547-06B8-44A9-B9FA-E6FE72413FB0Q37439146-409E6B67-63C1-47A6-AE77-35AEAD125A34Q38155902-C7325228-34D8-4AFF-BB7D-E105758C7BB0Q38569206-00AFAEB3-37DB-4DA3-B705-FE3E56F71854Q38826156-C16BA28F-7F36-4B4A-B16B-74D106C78D9AQ38981220-9625E6BD-7776-468F-893E-C0F8E6F863D2Q39505275-7A21848B-181B-43DE-A183-43E364EDEACAQ39713339-391B5D66-F220-4331-AF81-8074D182792EQ39869690-78FC42CA-F53A-47B3-A880-B4E6170733B7Q39938202-4CEA5A5C-42CF-4E5D-BC23-DC7949E8BE07Q41856204-D50419E5-1503-48A5-AC6C-1B10671122C5Q42845568-ACCEF6FD-3273-4E09-ACEE-C0CC1BFB8500Q49236261-C819263B-1320-48F6-B7D6-B1A7A74A51FD
P2860
Kinetics of histone H2AX phosphorylation and Chk2 activation in A549 cells treated with topotecan and mitoxantrone in relation to the cell cycle phase.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Kinetics of histone H2AX phosp ...... ation to the cell cycle phase.
@ast
Kinetics of histone H2AX phosp ...... ation to the cell cycle phase.
@en
Kinetics of histone H2AX phosp ...... ation to the cell cycle phase.
@nl
type
label
Kinetics of histone H2AX phosp ...... ation to the cell cycle phase.
@ast
Kinetics of histone H2AX phosp ...... ation to the cell cycle phase.
@en
Kinetics of histone H2AX phosp ...... ation to the cell cycle phase.
@nl
prefLabel
Kinetics of histone H2AX phosp ...... ation to the cell cycle phase.
@ast
Kinetics of histone H2AX phosp ...... ation to the cell cycle phase.
@en
Kinetics of histone H2AX phosp ...... ation to the cell cycle phase.
@nl
P2860
P50
P356
P1433
P1476
Kinetics of histone H2AX phosp ...... ation to the cell cycle phase.
@en
P2860
P304
P356
10.1002/CYTO.A.20574
P577
2008-06-01T00:00:00Z